Aptamer‐Guided CRISPR Systems Delivery: Precision Targeting Strategies, Translational Barriers, and Therapeutic Potential

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Advanced Therapeutics

• Publication date

  2026-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1002/adtp.202500395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic Genomic Imaging and Tracking in Living Cells by a DNA Origami‐Based CRISPR‒dCas9 System

  2025cited by this paper
• A Simplified Guide RNA Synthesis Protocol for SNAP- and Halo-Tag-Based RNA Editing Tools

  2025cited by this paper
• Modulating binding affinity of aptamer-based loading constructs enhances extracellular vesicle-mediated CRISPR/Cas9 delivery.

  2025cited by this paper
• A CRISPR/Cas12a-powered liquid crystal aptasensor for point-of-care detection of prostate-specific antigen for early-stage cancer diagnosis.

  2025influential reference
• CRISPR-Cas12a mediated magnetic aptasensors for direct detection of Brain-derived neurotrophic factor

  2025cited by this paper
• Programmable CRISPR-mediated gold nanoparticle adhesion for visual colorimetric detection.

  2025cited by this paper
• Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer.

  2024cited by this paper
• Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment.

  2024cited by this paper
• An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer

  2024cited by this paper
• Abstract 495: Targeting undruggable transcription factor HOXB13 in metastatic prostate cancer by CRISPR/Cas13d-based nanoparticle therapy

  2024cited by this paper
• Context-Responsive Nanoparticle Derived from Synthetic Zwitterionic Ionizable Phospholipids in Targeted CRISPR/Cas9 Therapy for Basal-like Breast Cancer.

  2024cited by this paper
• Controllable Assembly of a Quantum Dot-Based Aptasensor Guided by CRISPR/Cas12a for Direct Measurement of Circulating Tumor Cells in Human Blood.

  2024cited by this paper
• Endosomal escape: A bottleneck for LNP-mediated therapeutics

  2024cited by this paper
• DNA aptamer-conjugated lipid nanoparticle for targeted PTEN mRNA delivery to prostate cancer cells.

  2024cited by this paper
• Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane -liposome hybrid: BIRC5 gene knockout against melanoma.

  2024cited by this paper
• A comprehensive investigation of the biophysical approach for aptamer functionalized nanoparticles in cancer therapy: a review

  2024cited by this paper
• Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative

  2024cited by this paper
• Cutting-edge bioorthogonal chemistry: Innovations, practical applications, and emerging trends

  2024cited by this paper
• Confinement in Dual-Chain-Locked DNA Origami Nanocages Programs Marker-Responsive Delivery of CRISPR/Cas9 Ribonucleoproteins.

  2023cited by this paper
• CRISPR/Cas12a-based electrochemical aptasensor for determination of breast cancer-derived exosomes

  2023cited by this paper
• CRISPR/Cas12a-Derived Photoelectrochemical Aptasensor Based on Au Nanoparticle-Attached CdS/UiO-66-NH2 Heterostructures for the Rapid and Sensitive Detection of Ochratoxin A.

  2023cited by this paper
• CRISPR-Powered Aptasensor for Diagnostics of Alzheimer's Disease.

  2023cited by this paper
• Structural DNA nanotechnology at the nexus of next-generation bio-applications: challenges and perspectives

  2023cited by this paper
• Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity.

  2023cited by this paper
• Multi-aptamer–mediated hairpin allosteric and aptamer-assisted CRISPR system for detection of S. pneumoniae and S. aureus

  2023cited by this paper
• A Smart DNA Nanoassembly Containing Multivalent Aptamers Enables Controlled Delivery of CRISPR/Cas9 for Cancer Immunotherapy

  2023cited by this paper
• A DNA Origami-Based Gene Editing System for Efficient Gene Therapy in Vivo.

  2023cited by this paper
• CRISPR/Cas9 systems: Delivery technologies and biomedical applications

  2023cited by this paper
• Machine Learning-guided Lipid Nanoparticle Design for mRNA Delivery

  2023cited by this paper
• Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform

  2023cited by this paper
• Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing

  2023cited by this paper
• Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles

  2023cited by this paper
• AGILE Platform: A Deep Learning-Powered Approach to Accelerate LNP Development for mRNA Delivery

  2023cited by this paper
• Determination of adenosine by CRISPR-Cas12a system based on duplexed aptamer and molecular beacon reporter linked to gold nanoparticles

  2023cited by this paper
• CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

  2023cited by this paper
• Recent progress of aptamer‒drug conjugates in cancer therapy

  2023cited by this paper
• A CRISPR-Cas12a powered electrochemical sensor based on gold nanoparticles and MXene composite for enhanced nucleic acid detection

  2023cited by this paper
• Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging

  2022cited by this paper
• Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing

  2022cited by this paper
• Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry

  2022cited by this paper
• Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2′-fluoro and Locked Nucleic Acid Nucleotides

  2022cited by this paper
• Microfluidic formulation of lipid/ polymer hybrid nanoparticles for plasmid DNA (pDNA) delivery.

  2022cited by this paper
• RNA Aptamer-Functionalized Polymeric Nanoparticles in Targeted Delivery and Cancer Therapy: An up-to-date Review.

  2022cited by this paper
• Recent advances in aptamer-based targeted drug delivery systems for cancer therapy

  2022cited by this paper
• A CRISPR/Cas12a-responsive dual-aptamer DNA network for specific capture and controllable release of circulating tumor cells

  2022cited by this paper
• Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering

  2022cited by this paper
• Small-Molecule-Mediated Split-Aptamer Assembly for Inducible CRISPR-dCas9 Transcription Activation.

  2022cited by this paper
• Utilizing RNA origami scaffolds in Saccharomyces cerevisiae for dCas9-mediated transcriptional control

  2022cited by this paper
• CRISPR-Cas12a-mediated luminescence resonance energy transfer aptasensing platform for deoxynivalenol using gold nanoparticle-decorated Ti3C2Tx MXene as the enhanced quencher.

  2022cited by this paper
• Gold Nanoparticle‐Labeled CRISPR‐Cas13a Assay for the Sensitive Solid‐State Nanopore Molecular Counting

  2022cited by this paper
• In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System

  2022cited by this paper
• CRISPR-Cas12a-mediated label-free electrochemical aptamer-based sensor for SARS-CoV-2 antigen detection

  2022cited by this paper
• Programmable manipulation of oligonucleotide–albumin interaction for elongated circulation time

  2022cited by this paper
• Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells

  2022cited by this paper
• Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System

  2021cited by this paper
• Unraveling the promise and limitations of CRISPR/Cas system in natural product research: Approaches and challenges

  2021cited by this paper
• New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery

  2021cited by this paper
• Structural basis for Cas9 off-target activity

  2021cited by this paper
• Lipid nanoparticles for mRNA delivery

  2021cited by this paper
• A comparative analysis of cell surface targeting aptamers

  2021cited by this paper
• Chemical conjugation of nucleic acid aptamers and synthetic polymers

  2021cited by this paper
• CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.

  2021cited by this paper
• Aptamers and antibodies: rivals or allies in cancer targeted therapy?

  2021cited by this paper
• Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector.

  2021cited by this paper
• mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

  2021cited by this paper
• Artificial Intelligence in Aptamer–Target Binding Prediction

  2021cited by this paper
• Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro

  2021cited by this paper
• Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive Biosensing.

  2021cited by this paper
• Eligibility criteria and clinical trials: An FDA perspective.

  2021cited by this paper
• Nucleic-Acid Driven Cooperative Bioassays Using Probe Proximity or Split-Probe Techniques.

  2020cited by this paper
• Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

  2020cited by this paper
• FDA Approval and Regulation of Pharmaceuticals, 1983-2018.

  2020cited by this paper
• Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing

  2020influential reference
• Accurate MRSA identification through dual-functional aptamer and CRISPR-Cas12a assisted rolling circle amplification.

  2020cited by this paper
• Site-Selective and Rewritable Labeling of DNA through Enzymatic, Reversible, and Click Chemistries

  2020cited by this paper
• Diagnosis Setting and Colorectal Cancer Outcomes: The Impact of Cancer Diagnosis in the Emergency Department.

  2020cited by this paper
• Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

  2020cited by this paper
• Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications.

  2020cited by this paper
• Recent advances of thiol-selective bioconjugation reactions.

  2020cited by this paper
• Nanomedicines for Renal Management: From Imaging to Treatment.

  2020cited by this paper
• A versatile biosensing platform coupling CRISPR-Cas12a and aptamers for detection of diverse analytes.

  2020influential reference
• Cas9-edited immune checkpoint blockade PD-1 DNA polyaptamer hydrogel for cancer immunotherapy.

  2019cited by this paper
• WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

  2019cited by this paper
• System

  2019cited by this paper
• Aptamers Chemistry: Chemical Modifications and Conjugation Strategies

  2019cited by this paper
• The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

  2019cited by this paper
• Rational designs of in vivo CRISPR-Cas delivery systems.

  2019cited by this paper
• The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation

  2019cited by this paper
• On the role of helper lipids in lipid nanoparticle formulations of siRNA.

  2019cited by this paper
• Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications.

  2019cited by this paper
• Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia

  2019cited by this paper
• Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.

  2019cited by this paper
• Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning

  2019cited by this paper
• Aptamers for Targeted Delivery: Current Challenges and Future Opportunities

  2019cited by this paper
• CRISPR-based diagnostics

  2018cited by this paper
• Is CRISPR an Ethical Game Changer?

  2018cited by this paper
• Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials

  2018cited by this paper
• The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery.

  2018cited by this paper
• Pharmacokinetics, pharmacodynamics and safety of aptamers

  2018cited by this paper
• Specific Targeting of Oncogenes Using CRISPR Technology.

  2018cited by this paper

• No citing papers are available for this paper.